Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

1.860 +0.050 (+2.76%)
Streaming Delayed Price Updated: 3:58 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 98,597
Open 1.810
Bid (Size) 1.860 (2)
Ask (Size) 1.880 (13)
Prev. Close 1.810
Today's Range 1.766 - 1.920
52wk Range 0.8730 - 3.720
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fractyl Health Stock Is Trading Lower Monday: What's Going On?
Fractyl announced new preclinical data from its Rejuva Smart GLP-1 pancreatic gene therapy platform. 
Via Benzinga
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
From Fractyl Health, Inc.
Via GlobeNewswire

Performance

YTD
-12.7%
-12.7%
1 Month
+20.8%
+20.8%
3 Month
+14.1%
+14.1%
6 Month
+9.4%
+9.4%
1 Year
-17.3%
-17.3%

More News

Read More
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
From Fractyl Health, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
From Fractyl Health, Inc.
Via GlobeNewswire
Earnings Scheduled For May 13, 2025
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
Earnings Scheduled For March 3, 2025
Via Benzinga
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025
From Fractyl Health, Inc.
Via GlobeNewswire
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025
From Fractyl Health, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Fractyl Health, Inc. - Common Stock publicly traded?
Yes, Fractyl Health, Inc. - Common Stock is publicly traded.
What exchange does Fractyl Health, Inc. - Common Stock trade on?
Fractyl Health, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fractyl Health, Inc. - Common Stock?
The ticker symbol for Fractyl Health, Inc. - Common Stock is GUTS on the Nasdaq Stock Market
What is the current price of Fractyl Health, Inc. - Common Stock?
The current price of Fractyl Health, Inc. - Common Stock is 1.860
When was Fractyl Health, Inc. - Common Stock last traded?
The last trade of Fractyl Health, Inc. - Common Stock was at 08/04/25 03:58 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.